Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6165)
All Articles published online
|
Publishing Process of This Article
|
Aug 24, 2020 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chow AKM, Yau SWL, Ng L. Novel molecular targets in hepatocellular carcinoma. World J Clin Oncol 2020; 11(8): 589-605 [PMID: 32879846 DOI: 10.5306/wjco.v11.i8.589] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i8/589.htm |
| Number | Citing Articles |
| 1 |
Xudong Yang, Xiangdong Li. Oncogenic role of RNA-binding protein GNL2 in glioma: Promotion of tumor development through enhancing protein synthesis. Oncology Letters 2024; 28(1) doi: 10.3892/ol.2024.14440
|
| 2 |
Sidra Altaf, Faiza Saleem, Azam Ali Sher, Ashiq Ali. Potential Therapeutic Strategies to Combat HCC. Current Molecular Pharmacology 2022; 15(7): 929 doi: 10.2174/1874467215666220103111009
|
| 3 |
Yu Wang, Baocheng Deng. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers. Cancer and Metastasis Reviews 2023; 42(3): 629 doi: 10.1007/s10555-023-10084-4
|
| 4 |
Yanli Wang, Xiaoqing Zhu, Kailiang Wang, Ying Cai, Chunhua Liu, Jie Pan, Jia Sun, Ting Liu, Yong Huang, Yongjun Li, Yuan Lu. Cell metabolomics study on synergistic anti‐hepatocellular carcinoma effect of Aidi injection combined with doxorubicin. Biomedical Chromatography 2022; 36(10) doi: 10.1002/bmc.5451
|
| 5 |
Tingting Li, Tong Li, Zhiqiang Wang, Yingxue Jin. Cyclopeptide-based Anti-liver Cancer Agents: A Mini-review. Protein & Peptide Letters 2023; 30(3): 201 doi: 10.2174/0929866530666230217160717
|
| 6 |
Fernanda Villarruel-Melquiades, María Eugenia Mendoza-Garrido, Claudia M García-Cuellar, Yesennia Sánchez-Pérez, Julio Isael Pérez-Carreón, Javier Camacho. Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma. World Journal of Gastroenterology 2023; 29(17): 2571-2599 doi: 10.3748/wjg.v29.i17.2571
|
| 7 |
Patrizia Cioni, Edi Gabellieri, Barbara Campanini, Stefano Bettati, Samanta Raboni. Use of Exogenous Enzymes in Human Therapy: Approved Drugs and Potential Applications. Current Medicinal Chemistry 2022; 29(3): 411 doi: 10.2174/0929867328666210713094722
|
| 8 |
Junxiao Wang, Rui Liu, Yun Zhao, Zhenhu Ma, Zejie Sang, Zhenyu Wen, Xueling Yang, Hui Xie. Novel Microcrystal Formulations of Sorafenib Facilitate a Long-Acting Antitumor Effect and Relieve Treatment Side Effects as Observed With Fundus Microcirculation Imaging. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.743055
|
| 9 |
Nouf Juaid, Amr Amin, Ali Abdalla, Kevin Reese, Zaenah Alamri, Mohamed Moulay, Suzan Abdu, Nabil Miled. Anti-Hepatocellular Carcinoma Biomolecules: Molecular Targets Insights. International Journal of Molecular Sciences 2021; 22(19): 10774 doi: 10.3390/ijms221910774
|
| 10 |
Smriti Verma, Bidya Dhar Sahu, Madhav Nilakanth Mugale. Role of lncRNAs in hepatocellular carcinoma. Life Sciences 2023; 325: 121751 doi: 10.1016/j.lfs.2023.121751
|
| 11 |
Ester Jo, Kush Savsani, Anjelica Alfonso, Andrew Park, Seung Duk Lee, Devanand Sakar, Nathaniel Kinsey, Yuzuru Sambommatsu, Daisuke Imaid, Aamir Khan, Amit Sharma, Muhammad Saeed, Vinay Kumaran, Adrian Cotterell, Marlon Levy, David Bruno. Photodynamic effect of indocyanine green and its application to hepatocellular carcinoma treatment. Journal of Cancer Metastasis and Treatment 2024; doi: 10.20517/2394-4722.2024.18
|
| 12 |
Guilherme Ribeiro Romualdo, Kaat Leroy, Cícero Júlio Silva Costa, Gabriel Bacil Prata, Bart Vanderborght, Tereza Cristina da Silva, Luís Fernando Barbisan, Wellington Andraus, Lindsey Devisscher, Niels Olsen Saraiva Câmara, Mathieu Vinken, Bruno Cogliati. In Vivo and In Vitro Models of Hepatocellular Carcinoma: Current Strategies for Translational Modeling. Cancers 2021; 13(21): 5583 doi: 10.3390/cancers13215583
|
| 13 |
Chang Xu, Xudong Gao, Tianshu Ren, Hefeng Geng, Kaisi Yang, Yaoguang Huang, Weige Zhang, Shanbo Hou, Aigang Song, Yingshi Zhang, Qingchun Zhao. The ADAM17 inhibitor ZLDI-8 sensitized hepatocellular carcinoma cells to sorafenib through Notch1-integrin β-talk. Pharmacological Research 2024; 203: 107142 doi: 10.1016/j.phrs.2024.107142
|
| 14 |
Noriko Yamada, Rie Matsushima-Nishiwaki, Kaido Kobayashi, Junko Tachi, Osamu Kozawa. GLP-1 reduces the migration of hepatocellular carcinoma cells via suppression of the stress-activated protein kinase/c-Jun N-terminal kinase pathway. Archives of Biochemistry and Biophysics 2021; 703: 108851 doi: 10.1016/j.abb.2021.108851
|
| 15 |
Jing-Yi Mou, Zhang-Wen Ma, Meng-Ying Zhang, Quan Yuan, Zi-Yi Wang, Qing-Hua Liu, Fen Li, Zhao Liu, Liang Wang. Structural abnormality of hepatic glycogen in rat liver with diethylnitrosamine-induced carcinogenic injury. International Journal of Biological Macromolecules 2024; 260: 129432 doi: 10.1016/j.ijbiomac.2024.129432
|